Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.58 USD | +2.13% | -0.21% | -14.77% |
05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
05-13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.77% | 465M | |
+29.98% | 682B | |
+31.89% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.42% | 240B | |
+9.37% | 209B | |
-9.24% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Theravance Biopharma : Needham Adjusts Theravance Biopharma's Price Target to $18 From $32, Keeps Buy Rating